Cardiovascular Nuclear Medicine Track
The 2022 meeting will feature a dedicated track on cardiovascular nuclear medicine. This program will highlight basic concepts in nuclear cardiac imaging and stress testing, as well as exciting new areas -- all designed to provide you with tangible outcomes to optimize how cardiovascular imaging helps you treat your patients.
Friday, February 25
2:00–3:30 pm ET
Imaging Guided Management of CAD
Sponsored by the SNMMI Cardiovascular Council
Organizers/Moderators: Terrence Ruddy, MD, FRCPC, FACC, FSNMMI, MASNC; Vasken Dilsizian, MD, FACC, FAHA, MASNC, FSNMMI
Session Objectives
- Compare and contrast the strengths and limitations of the2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain.
- Select the appropriate cardiac noninvasive test for the patient with known or suspected CAD.
- Discuss the role of imaging in selecting patients for coronary revascularization
Presentations Include:
- 2021 AHA/ACC Guidelines for Chest Pain
Randall Thompson, MD
- Select between Different Test VS No Testing
Mouaz Al-Mallah, MD, MSC, FACC
- Imaging-based Revascularization
Krishna Patel, MD
- Case Discussion
Roxana Campisi, MD
- Q&A
3:45 am–5:15 pm ET
Blood Flow Quantification
Sponsored by the SNMMI Cardiovascular Council
Organizers: Keisha C. McCall, PhD
Moderators: Chi Liu, PhD
Session Objectives
- Discuss the process and procedures of performing dynamic SPECT studies to quantify MBF and CFR
- Examine the accuracy between SPECT-derived MBF and PET-derived MBF
- Discuss clinical case studies of MBF quantification using SPECT
Presentations Include:
- How to Quantify Blood Flow with SPECT
Terrence Ruddy, MD, FRCPC, FACC, FCCS, FSNMMI, MASNC
- PET vs SPECT MBF
R. Glenn Wells, PhD
- Clinical Implementation of Blood Flow SPECT
Ronald G. Schwartz, MD, MS, FACC, FAHA
- Case Discussion
Ronald G. Schwartz, MD, MS, FACC, FAHA
5:30–7:00 pm ET
New Cardiac Radiotracers
Sponsored by the SNMMI Cardiovascular Council
Organizers/Moderators: Rene R. Packard, MD, PhD and Stephan Nekolla
Session Objectives
- Appreciate the role of active calcification processes in aortic stenosis progression
- Discuss the utility of 18F-NaF PET for prediction of disease progression
- Describe the utility of 18F-NaF PET for prediction of bioprosthetic valve failure
Presentations Include:
- Aortic Stenosis Imaging NaF PET
Jacek Kwiecinski, MD, PhD
- Ga68-FAPI and F18-GP1 for Cardiac Imaging
Michelle Williams, MBChB, PhD, MRCP, FRCR, FSCCT
- 18F-Flurpiridaz for Myocardial Perfusion Imaging and Flow Quantitation
Jamshid Maddahi, MD, FACC, FASNC
- New Amyloid PET Tracers
Sharmila Dorbala, MD, MPH, MASNC
- Q&A
Saturday, February 26
10:00–11:30 am ET
New Cardiac Instrumentation
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: James R. Galt, PhD
Session Objectives
- Elaborate on the benefits of the use of direct photon detection with CZT in SPECT imaging.
- Describe the difference between digital and analog PET systems and list the benefits of digital PET when incorporated into clinical PET/CT scanners
- Explain the factors impacting the use of PET/MR in cardiac imaging, including the benefits and disadvantages compared to PET/CT.
Presentations Include:
- New Camera Technology: CZT SPECT
Keisha McCall, PhD
- New Digital PET
Mi-Ae Park, PhD
- New Reconstruction Methods
James Case, PhD
- PET/MR
Frank Prato, PhD, FCCPM, ABMP, FCOMP, FURSI, FCAHS
- Q&A
11:45 am–1:15 pm ET
New Software/AI for Cardiac SPECT and PET
Sponsored by the SNMMI Cardiovascular Council
Organizer: Professor Reimer Slart, MD, PhD
Moderator: Piotr J. Slomka, PhD
Session Objectives
- Examine the role of AI in SPECT and PET MPI
- Discuss value of databases in AI
- Improve clinical practice in MPI using smart technical adaptions
Presentations Include:
- Databases for AI: REFINE SPECT
Piotr J. Slomka, PhD
- Deep Learning for Diagnosis and Prognosis
Ananya Singh
- Low Dose SPECT and Image Improvement with AI
Michael A. King, PhD, DABR, FSNMMI
- Attenuation Correction without CT
Chi Liu, PhD
2:30–4:00 pm ET
Cardiac Hybrid Imaging
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: Saurabh Malhotra, MD, PhD
Session Objectives
- Appreciate integration of anatomic and perfusion imaging data.
- Critique the incremental value of CTA over MPI.
- Examine the evaluation and reporting of incidental CT findings.
Presentations Include:
- Session Reading CT for Incidentals?
Domenico Albano, MD
- PET/CTA for CAD
Dominik Benz-Vittori, MD
- Case-Based Discussion
Timothy Bateman, MD
- Q&A
4:15–5:45 pm ET
Imaging of Cardiac Sarcoidosis
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: Panithaya Chareonthaitawee, MD; Thomas Schindler, MD
Session Objectives
- Discuss how to perform PET for Sarcoidosis
- Describe how to interpret and report cardiac sarcoidosis PET studies
- Compare and contrast PET vs MRI for cardiac sarcoidosis
Presentations Include:
- How to Perform PET for Sarcoidosis
Panithaya Chareonthaitawee, MD
- Interpretation and Reporting: Step by Step Approach
Edward J. Miller, MD PhD FASNC FACC
- PET, CMR or Both?
Marc Dweck, BSc, MBChB, PhD, FRCP, FACC
- Challenging Cases
Cesia Gallegos Kattan, MD
Sunday, February 27
10:00–11:30 am ET
Cardiovascular Session - Details TBA
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: Krishna Patel, MD
Session Objectives
- Discuss how to acquire and perform quality control on myocardial flow data with cardiac PET
- Examine how to integrate quantitative myocardial flow data in clinical reporting of perfusion PET
- Determine how to use quantitative myocardial flow information on PET in diagnosis and management of coronary microvascular dysfunction
- Discuss how to use cardiac PET with flow quantitation to diagnose post transplant coronary allograft vasculopathy
Presentations Include:
- How to Quality Control
Venkatesh L. Murthy, MD
- How to Integrate in Clinical Reports
Rob Beanlands, MD
- PET for Microvascular Dysfunction
Viviany Taqueti, MD, MPH
- PET for Transplants
Atilla Feher, MD, PhD
- Q&A
11:45 am–1:15 pm ET
Radionuclide Imaging in Cardiac Amyloidosis
Sponsored by the SNMMI Cardiovascular Council
Organizers/Moderators: Jamieson Bourque, MD, MHS; Timothy Bateman, MD
Session Objectives
- Apply radionuclide imaging in the screening for cardiac amyloidosis
- Appropriately select testing for diagnosis of cardiac amyloidosis
- Optimize SPECT imaging for the evaluation of cardiac amyloidosis.
Presentations Include:
- Screening for Cardiac Amyloidosis
Saurabh Malhotra, MD, MPH
- Appropriate Use Criteria in the Evaluation of Cardiac Amyloidosis
Brett W. Sperry, MD
- SPECT Imaging in Cardiac Amyloidosis
Robert Miller, MD
- Cases in Cardiac Amyloidosis
Cigdem Akincioglu, MD
2:30–4:00 pm ET
Clinical Controversies Relevant to Cardiac Imaging
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: Panithaya Chareonthaitawee, MD
Session Objectives
- Describe the role of SPECT MPI following the ISCHEMIA trial
- Explain the pros and cons of low-dose and rapid SPECT MPI acquisition
- Compare the use of WBC scintigraphy vs FDG PET for infection imaging
Presentations Include:
- Nuclear Cardiology Post-ISCHEMIA
Venkatesh L. Murthy, MD, PhD
- Low Dose or Fast SPECT MPI
Terrence Ruddy, MD, FRCPC, FACC, FSNMMI, MASNC
- WBC Scintigraphy or FDG PET for Cardiac Infection
Paola Anna Erba, MD
- How to Use Quantification in FDG PET Imaging for Cardiac Infection and Inflammation
Sharmila Dorbala, MD
4:15–5:45 pm ET
Cardiac Infection Imaging
Sponsored by the SNMMI Cardiovascular Council
Organizer/Moderator: Thomas Schindler, MD
Session Objectives
- Describe how to perform FDG PET imaging for cardiac infection
- Discuss the role of FDG PET in prosthetic valve endocarditis
- Discuss the role of FDG PET in cardiac device infection
Presentations Include:
- How to Perform Infection Imaging
Panithaya Chareonthaitawee, MD
- Prosthetic Valve Endocarditis
Riemer Slart, MD, PhD
- Cardiac Device Infection Imaging
Vasken Dilsizian, MD, FSNMMI
- Case Discussion
Wael A. Jaber, MD